Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Exact Sciences (EXAS) Tops Q4 EPS by 5c
February 21, 2017 6:03 AM ESTExact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.34), $0.05 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $35.2 million versus the consensus estimate of $33.19 million.
2017 Outlook
"We intend to build on last year's success by contracting with additional payers,... More



